These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 31315433)

  • 21. Inhibition of Local Macrophage Growth Ameliorates Focal Inflammation and Suppresses Atherosclerosis.
    Yamada S; Senokuchi T; Matsumura T; Morita Y; Ishii N; Fukuda K; Murakami-Nishida S; Nishida S; Kawasaki S; Motoshima H; Furukawa N; Komohara Y; Fujiwara Y; Koga T; Yamagata K; Takeya M; Araki E
    Arterioscler Thromb Vasc Biol; 2018 May; 38(5):994-1006. PubMed ID: 29496659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myeloid
    Zhu W; Liang W; Lu H; Chang L; Zhang J; Chen YE; Guo Y
    Cells; 2022 Sep; 11(18):. PubMed ID: 36139452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin-like growth factor I reduces lipid oxidation and foam cell formation via downregulation of 12/15-lipoxygenase.
    Sukhanov S; Snarski P; Vaughn C; Lobelle-Rich P; Kim C; Higashi Y; Shai SY; Delafontaine P
    Atherosclerosis; 2015 Feb; 238(2):313-20. PubMed ID: 25549319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Grb2 is required for atherosclerotic lesion formation.
    Proctor BM; Ren J; Chen Z; Schneider JG; Coleman T; Lupu TS; Semenkovich CF; Muslin AJ
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1361-7. PubMed ID: 17363695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intermedin inhibits macrophage foam-cell formation via tristetraprolin-mediated decay of CD36 mRNA.
    Dai XY; Cai Y; Sun W; Ding Y; Wang W; Kong W; Tang C; Zhu Y; Xu MJ; Wang X
    Cardiovasc Res; 2014 Feb; 101(2):297-305. PubMed ID: 24253523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. UFM1 Protects Macrophages from oxLDL-Induced Foam Cell Formation Through a Liver X Receptor α Dependent Pathway.
    Pang Q; Xiong J; Hu XL; He JP; Liu HF; Zhang GY; Li YY; Chen FL
    J Atheroscler Thromb; 2015; 22(11):1124-40. PubMed ID: 26040753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-Lethal Sonodynamic Therapy Inhibits Atherosclerotic Plaque Progression in ApoE-/- Mice and Attenuates ox-LDL-mediated Macrophage Impairment by Inducing Heme Oxygenase-1.
    Wang Y; Wang W; Xu H; Sun Y; Sun J; Jiang Y; Yao J; Tian Y
    Cell Physiol Biochem; 2017; 41(6):2432-2446. PubMed ID: 28468003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The macrophage C-type lectin receptor CLEC5A (MDL-1) expression is associated with early plaque progression and promotes macrophage survival.
    Xiong W; Wang H; Lu L; Xi R; Wang F; Gu G; Tao R
    J Transl Med; 2017 Nov; 15(1):234. PubMed ID: 29126450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tofacitinib ameliorates atherosclerosis and reduces foam cell formation in apoE deficient mice.
    Wang Z; Wang S; Wang Z; Yun T; Wang C; Wang H
    Biochem Biophys Res Commun; 2017 Aug; 490(2):194-201. PubMed ID: 28601639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myeloid-Specific Deletion of Epsins 1 and 2 Reduces Atherosclerosis by Preventing LRP-1 Downregulation.
    Brophy ML; Dong Y; Tao H; Yancey PG; Song K; Zhang K; Wen A; Wu H; Lee Y; Malovichko MV; Sithu SD; Wong S; Yu L; Kocher O; Bischoff J; Srivastava S; Linton MF; Ley K; Chen H
    Circ Res; 2019 Feb; 124(4):e6-e19. PubMed ID: 30595089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. nSMase2 (Type 2-Neutral Sphingomyelinase) Deficiency or Inhibition by GW4869 Reduces Inflammation and Atherosclerosis in Apoe
    Lallemand T; Rouahi M; Swiader A; Grazide MH; Geoffre N; Alayrac P; Recazens E; Coste A; Salvayre R; Nègre-Salvayre A; Augé N
    Arterioscler Thromb Vasc Biol; 2018 Jul; 38(7):1479-1492. PubMed ID: 29794115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypoxia-inducible protein 2 Hig2/Hilpda mediates neutral lipid accumulation in macrophages and contributes to atherosclerosis in apolipoprotein E-deficient mice.
    Maier A; Wu H; Cordasic N; Oefner P; Dietel B; Thiele C; Weidemann A; Eckardt KU; Warnecke C
    FASEB J; 2017 Nov; 31(11):4971-4984. PubMed ID: 28760743
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ox-LDL-Induced MicroRNA-155 Promotes Autophagy in Human Endothelial Cells via Repressing the Rheb/ mTOR Pathway.
    Lv J; Yang L; Guo R; Shi Y; Zhang Z; Ye J
    Cell Physiol Biochem; 2017; 43(4):1436-1448. PubMed ID: 29017169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leukocyte Calpain Deficiency Reduces Angiotensin II-Induced Inflammation and Atherosclerosis But Not Abdominal Aortic Aneurysms in Mice.
    Howatt DA; Balakrishnan A; Moorleghen JJ; Muniappan L; Rateri DL; Uchida HA; Takano J; Saido TC; Chishti AH; Baud L; Subramanian V
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):835-45. PubMed ID: 26966280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. microRNA-212 promotes lipid accumulation and attenuates cholesterol efflux in THP-1 human macrophages by targeting SIRT1.
    Miao H; Zeng H; Gong H
    Gene; 2018 Feb; 643():55-60. PubMed ID: 29174964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological activation of the melanocortin system limits plaque inflammation and ameliorates vascular dysfunction in atherosclerotic mice.
    Rinne P; Silvola JM; Hellberg S; Ståhle M; Liljenbäck H; Salomäki H; Koskinen E; Nuutinen S; Saukko P; Knuuti J; Saraste A; Roivainen A; Savontaus E
    Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1346-54. PubMed ID: 24790139
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disruption of mammalian target of rapamycin complex 1 in macrophages decreases chemokine gene expression and atherosclerosis.
    Ai D; Jiang H; Westerterp M; Murphy AJ; Wang M; Ganda A; Abramowicz S; Welch C; Almazan F; Zhu Y; Miller YI; Tall AR
    Circ Res; 2014 May; 114(10):1576-84. PubMed ID: 24687132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Curcumin modulation of high fat diet-induced atherosclerosis and steatohepatosis in LDL receptor deficient mice.
    Hasan ST; Zingg JM; Kwan P; Noble T; Smith D; Meydani M
    Atherosclerosis; 2014 Jan; 232(1):40-51. PubMed ID: 24401215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proteoglycan 4 regulates macrophage function without altering atherosclerotic lesion formation in a murine bone marrow-specific deletion model.
    Nahon JE; Hoekstra M; Havik SR; Van Santbrink PJ; Dallinga-Thie GM; Kuivenhoven JA; Geerling JJ; Van Eck M
    Atherosclerosis; 2018 Jul; 274():120-127. PubMed ID: 29772480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Macrophage KLF15 prevents foam cell formation and atherosclerosis via transcriptional suppression of OLR-1.
    Song ZK; Zhao L; Liu DS; Zhao LN; Peng QB; Li ZY; Wu JY; Chen SK; Huang FZ; Chen X; Lin TX; Guan L; Meng WP; Guo JW; Su YN; He XX; Liang SJ; Zhu P; Zheng SY; Du SL; Liu X
    J Mol Cell Cardiol; 2024 Jan; 186():57-70. PubMed ID: 37984156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.